Here, we show that differentiation of CSCs increases resistance to TMZ but not to RT, and that transcriptional responses to these treatments are largely regulated by p53 in wildtype (wt) p53 GBM cells and modulated by cell differentiation state. This evidence concerns the gene TP53 and glioblastoma.